# Caribou Property

> Caribou Property is a VC fund backing Biotechnology, Therapeutics and Genetics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Mar 2022
- Lead investor: 25%
- Last updated: Aug 2026

Caribou Property is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 100% |
| Therapeutics | 3 | 75% |
| Genetics | 1 | 25% |
| Biopharma | 1 | 25% |
| Health Care | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series B | 1 | 25% |
| Funding Round | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Epsilogen | IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor. | $41.2M | Series B | Mar 02, 2022 |  |
| Macomics | Macomics is an immuno-oncology company. Macomics focus on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defence against tumours. | $5.9M | Seed | Jul 29, 2021 |  |
| Lunac Therapeutics | Epidarex Capital invests in early-stage, high growth life science and health technology Epidarex Capital is a transatlantic venture fund that invests in early-stage, high growth life science and health technology companies in under-ventured markets. | $6.7M | Venture - Series Unknown | May 17, 2021 |  |
| Edinburgh Molecular Imaging | Edinburgh Molecular Imaging, a Scottish (UK) developer of optical molecular imaging technology. EM Imaging was founded in 2014 by an experienced team of scientists & clinicians. Together they have raised over £15 Million in non-dilutive funding from the Wellcome Trust, EPSRC and MRC to develop a unique range of SMART Agents that enablereal-time molecular imaging for the diagnosis of a variety of disease states.The EM Imaging team has decades of documented success in imaging agent discovery and development with expertise spanning medicinal chemistry, biochemistry and cell biology, along with direct clinical expertise. The team also has significant expertise in the clinical development, approval and reimbursement of molecular imaging agents. | $3.9M |  | Dec 17, 2019 |  |

4 of 4 investments shown.

## Co-investors
- [Epidarex Capital](https://shizune.co/investors/profile/epidarex-capital) — VC Fund, 3 deals together
- [ALSA Ventures](https://shizune.co/investors/profile/alsa-ventures) — VC Fund, 1 deal together
- [British Patient Capital](https://shizune.co/investors/profile/british-patient-capital) — VC Fund, 1 deal together
- [3B Future Health Fund](https://shizune.co/investors/profile/helsinn-investment-fund) — VC Fund, 1 deal together
- [Northern Powerhouse Investment Fund](https://shizune.co/investors/profile/northern-powerhouse-investment-fund) — VC Fund, 1 deal together
- [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Greylock](https://shizune.co/investors/profile/greylock) — VC Fund
- [Lerer Hippeau](https://shizune.co/investors/profile/lerer-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Photography Investors in United Kingdom](https://shizune.co/investors/photography-investors-united-kingdom)
- [Photography VC Funds in United Kingdom](https://shizune.co/investors/photography-vc-funds-united-kingdom)

## FAQ

### What does Caribou Property invest in?

Caribou Property invests primarily in Biotechnology, Therapeutics and Genetics startups, most often at Seed and Series B stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Caribou Property last invest?

The most recent investment recorded for Caribou Property closed in Mar 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co